The benefits of AI in early drug discovery and clinical trials - Jackie Hunter, BenevolentAI

Professor Jackie Hunter | Discovery Research | Policy Lates 2020 | Royal Society of BiologyПодробнее

The search for new drugs can't be left in human handsПодробнее

The benefits of AI in drug developmentПодробнее

How will AI impact clinical healthcare?Подробнее

BenevolentBio's Professor Jackie Hunter on Transforming Drug Discovery at Disrupt London 2016Подробнее

#GBMDay: An AI-Enabled Approach to GBM Drug DiscoveryПодробнее

BenevolentAI · AI-Enabled Drug DiscoveryПодробнее

This is the 1st drug designed by generative AI in human clinical trialsПодробнее

Layoff 2023 || BenevolentAI || AI platform for drug discovery and development.😥Подробнее

Challenges of designing an AI platform for Drug Discovery w/ Marek KultysПодробнее

BenevolentAI’s Innovation Week: pushing the boundaries of AI in drug discoveryПодробнее

How #AI and Machine Learning can accelerate drug discovery and developmentПодробнее

Innovation in AI for Target Identification & Drug Discovery, Anne Phelan, CSO BenevolentAIПодробнее

'We are in it for the long run,' says Odyssey Acquisition on BenevolentAI mergerПодробнее

BenevolentAI & AstraZeneca: Fusing AI and Drug Discovery Expertise to Find New Treatments for CKDПодробнее

Keynote Panel: The benefits of AI within drug discoveryПодробнее

Revolutionising drug discovery with AIПодробнее

How will AI driven drug discovery make future medicines more affordable? Ken Mulvany, BenevolentAIПодробнее

IDEA Collider | Jackie HunterПодробнее